Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2017-01-23 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
独立董事对公司第七届董事会临时会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a board meeting resolution regarding the extension of the validity period of a non-public stock issuance shareholders' meeting resolution. It references compliance with company law, securities law, and stock exchange rules, and discusses the board meeting procedures and voting. The content focuses on board/management decisions and opinions rather than financial results, audit, or shareholder voting results. It is not a full annual or interim report, nor an earnings release or regulatory filing. The document is best classified as Board/Management Information (MANG) because it relates to board meeting decisions and independent directors' opinions on corporate governance matters.
2017-01-23 Chinese
独立董事对公司第七届董事会临时会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the extension of the validity period of a non-public stock issuance shareholders' meeting resolution. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange listing rules. The content is about board-level approval and compliance with governance and regulatory requirements, specifically related to a board meeting agenda item. The document is short (527 characters) and does not contain financial statements or detailed financial data. It is not an announcement of voting results, nor a full report or presentation. It is a governance-related document expressing independent directors' pre-approval opinions on board meeting proposals. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management matters.
2017-01-23 Chinese
第七届董事会临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at a temporary board meeting of the company, specifically regarding the extension of the validity period for a non-public stock issuance shareholder meeting resolution and related authorizations. It includes voting results and procedural details but does not contain financial statements or detailed financial data. The document is relatively short (2107 characters) and serves as a notification of board decisions and upcoming shareholder meeting matters. It is not an annual report, audit report, earnings release, or any detailed financial report. It is also not a proxy solicitation or voting results announcement, as it pertains to board meeting resolutions rather than shareholder vote outcomes. The content fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2017-01-23 Chinese
关于延长非公开发行股票股东大会决议和授权有效期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the extension of the validity period of a shareholders' meeting resolution and authorization related to a non-public stock issuance. It discusses board and shareholder meeting decisions, authorization extensions, and regulatory approval status. The document is short (1114 characters) and serves as a formal announcement of these corporate governance and procedural updates rather than a detailed financial report or full filing. It does not contain financial statements or detailed financial data. The content fits best under Capital/Financing Update (CAP) because it relates to the company's non-public stock issuance process and related shareholder and board authorizations.
2017-01-23 Chinese
第七届监事会临时会议决议公告
Board/Management Information Classification · 90% confidence The document is a formal announcement from the supervisory board (监事会) of 启迪古汉集团股份有限公司 regarding the extension of the validity period of a shareholders' meeting resolution related to a non-public stock issuance. It details the meeting date, attendance, and the specific agenda item about extending the resolution validity period. There is no financial data, no full report, no earnings or audit information, and no presentation materials. The document is an official announcement of a board/supervisory meeting decision related to corporate governance and capital issuance matters. It is not a full capital/financing update report but an announcement of a board resolution. Given the content, the best fitting category is Board/Management Information (MANG), as it relates to board/supervisory decisions and announcements about company governance and capital issuance approvals.
2017-01-23 Chinese
关于召开2017年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2017 first extraordinary general meeting (临时股东大会) of the company 启迪古汉集团股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed, and instructions for shareholders on how to participate and vote. The document also contains attachments such as the proxy authorization form and voting procedures. There is no financial data or report content; rather, it is an announcement and procedural guide for a shareholders' meeting. This fits the category of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2017-01-23 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.